Introduction: Basal glucose control in diabetes type 2 is commonly maintained by a single, once-daily administration of insulin through subcutaneous injection. Insulin icodec, novel ultralong-acting lipidated analog validates the concept once-weekly basal injection that less burdensome, yet equally safe and efficacious as conventional treatment 1.Aim: The aim study to introduce injected therapy...

AIM Type 2 diabetes is associated with an increased risk of fractures. There are a few studies on the effects of diabetes treatment on fracture risk. The aim was to investigate the fracture risk related to various types of insulin therapy in primary care practices. METHODS Data from 105,960 type 2 diabetes patients from 1,072 general and internal medicine practices in Germany were retrospecti...

We attempted to examine whether withdrawal from insulin therapy is or is not possible with administration of additional alogliptin and identify the contributing factors. The subjects were 43 adult patients with type 2 diabetes undergoing insulin therapy after admission. After glucotoxicity was removed, 25 mg alogliptin was additionally administered. Insulin was reduced by 15.6 ± 13.0 units (mea...

OBJECTIVE To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates...

BACKGROUND This retrospective study investigated the effect of adding metformin to pharmacologic insulin dosing in type 1 diabetics on insulin therapy 1 year after treatment compared with patients on insulin therapy alone. METHODS Twenty-nine adults with type 1 diabetes who had metformin added to their insulin therapy for 12 months were compared with 29 adults with type 1 diabetes who remaine...

AIMS To evaluate whether perception of insulin therapy differs between patients with type 2 diabetes treated with insulin and those treated with oral hypoglycaemic agents (OHAs), and to examine whether gender, education level, injection duration and mode of injection were associated with the patients' perception of insulin therapy. METHODS The validated Chinese version of the Insulin Treatmen...

OBJECTIVES Type 2 diabetes is a significant healthcare problem in the Latino/Hispanic community. As with most patients with type 2 diabetes, Latino patients will eventually require insulin therapy to maintain glycemic control. Some cultural barriers to starting insulin therapy among Latino patients have been reported. This review explores the implications of the increasing prevalence of type 2 ...

Gestational diabetes mellitus (GDM) is a serious and frequent concern in pregnancy. Worldwide, the prevalence of GDM ranges from 8 to 20%. In 5% cases, this pathology accompanied by complications such as diabetic fetopathy, preeclampsia, neonatal hypoglycemia, hyperbilirubinemia. Modern national foreign guidelines for detecting hyperglycemia during pregnancy diagnosing recommend lifestyle chang...

conclusions the applied therapy adaptation before and after exercises was adequate to avoid hypoglycemia while using an ultra-long-acting insulin. objectives the aim of this experimental, cross-sectional study was to investigate exercise intensity-dependent, short-acting insulin reductions to avoid hypoglycemia, applying standardized exercises using insulin degludec (®tresiba/novo nordisk, denm...